This review highlights recent developments in the physiology and pharmacology of key cardiac ion channels for therapeutic development and elucidates mechanisms for drug-induced cardiac side effects.
Cardiac pathophysiologies (e.g., atrial fibrillation, angina)
Cardiac ion channels
Ion channels are critical for all aspects of cardiac function, including rhythmicity and contractility. Consequently, ion channels are key targets for therapeutics aimed at cardiac pathophysiologies such as atrial fibrillation or angina. At the same time, off-target interactions of drugs with cardiac ion channels can be the cause of unwanted side effects. This manuscript aims to review the physiology and pharmacology of key cardiac ion channels. The intent is to highlight recent developments for therapeutic development, as well as elucidate potential mechanisms for drug-induced cardiac side effects, rather than present an in-depth review of each channel subtype.
Building similarity graph...
Analyzing shared references across papers
Loading...
Priest et al. (Thu,) conducted a review in Cardiac pathophysiologies (e.g., atrial fibrillation, angina). Cardiac ion channels was evaluated. This review highlights recent developments in the physiology and pharmacology of key cardiac ion channels for therapeutic development and elucidates mechanisms for drug-induced cardiac side effects.
synapsesocial.com/papers/6a24d2fbc00a3bd03029ac83 — DOI: https://doi.org/10.1080/19336950.2015.1076597
Birgit T. Priest
Eli Lilly (United States)
Jeff S. McDermott
Eli Lilly (United States)
Channels
Eli Lilly (United States)
Building similarity graph...
Analyzing shared references across papers
Loading...
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: